Claris Recalls Ciprofloxacin, Metronidazole and Ondansetron

Washington, DC: Claris Lifesciences has initiated a nationwide recall of all lots of Ciprofloxacin Inj. USP 200 mg / 100 mL (NDC 36000-008-24), Ciprofloxacin Inj. USP 400 mg / 200 mL (NDC 36000-009-24), Metronidazole Inj. USP 500 mg/100 ml (NDC 36000-001-24), and Ondansetron in 5% Dextrose Inj. 32 mg / 50 mL (36000-014-06) manufactured and distributed by Claris Lifesciences. All lots are being recalled, which were distributed to hospitals, wholesalers and distributors nationwide.

Claris has initiated this recall to the user level as a precautionary measure against possible contamination due to packaging integrity of the product. Claris has received reports that the products listed above may contain floating matter which may pose risk if administered to patients.

Legal Help

If you or a loved one has suffered an adverse health event or illness as a result of exposure to any of the above products, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Published on Jun-3-10